The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness
Abstract
Urokinase and its receptor are essential components of the cell migration machinery, providing an inducible, transient and localized cell surface proteolytic activity. This activity has been shown to be required in normal and pathological forms of cellular invasiveness (i.e. in several embryonic developmental processes, during inflammatory responses and cancer metastasis and spreading). It represents one of the best known of the protcolytic systems which are currently under investigation in this field. The urokinase receptor allows a continuous regulation of the proteolytic activity at cell contacts, utilizing the different localization of urokinase and its inhibitors. The receptor, in fact, in addition to focusing the enzymatic activity at focal and cell‐cell contacts, also regulates it by internalizing and degrading only the inhibited form of urokinase. Internalized receptor releases the ligands to the lysosomes and recycles back to surface. In this way, the proteolytically active areas of the cell surface can be continuously monitored for their activity and their location modified. The cell can thus coordinate its migration efforts with a step‐wise modification of the proteolytic activity‐map of the cell surface. The urokinase cycle can be supported by one individual cell (autocrine) or by two or more cells. In the latter case, complementation and synergism of urokinase and its receptor are found.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535
The matrix‐degrading metalloproteinases
Matrisian, L. M. (1992) · BioEssays · doi:10.1002/bies.950140705 · Cited by 1,364
Sato, Y., & Rifkin, D. B. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.1.309 · Cited by 905
Huber, R., & Carrell, R. W. (1989) · Biochemistry · doi:10.1021/bi00449a001 · Cited by 883
Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade
Mignatti, P., Robbins, E., & Rifkin, D. B. (1986) · Cell · doi:10.1016/0092-8674(86)90613-6 · Cited by 746
A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
Vassalli, J. D., Baccino, D., & Belin, D. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.1.86 · Cited by 712
Antibodies to plasminogen activator inhibit human tumor metastasis
Ossowski, L., & Reich, E. (1983) · Cell · doi:10.1016/0092-8674(83)90093-4 · Cited by 634
Roldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Danø, K., Appella, E., & Blasi, F. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08132.x · Cited by 603
Self-citationPloug, M., Rønne, E., Behrendt, N., Jensen, A. L., Blasi, F., & Danø, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52382-6 · Cited by 574
Self-citationAppella, E., Robinson, E. A., Ullrich, S. J., Stoppelli, M. P., Corti, A., Cassani, G., & Blasi, F. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61211-6 · Cited by 475
Self-citation
Cited by
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Functions of hyaluronan in wound repair
CHEN, W. Y. J., & ABATANGELO, G. (1999) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.1999.00079.x · Cited by 1,081
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
Bajou, K., Noël, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-923 · Cited by 677
Lillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., & Strickland, D. K. (2008) · Physiological Reviews · doi:10.1152/physrev.00033.2007 · Cited by 669
Ovulation: Parallels With Inflammatory Processes
Duffy, D. M., Ko, C., Jo, M., Brannstrom, M., & Curry, T. E. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00075 · Cited by 513
Okada, A., Bellocq, J. P., Rouyer, N., Chenard, M. P., Rio, M. C., Chambon, P., & Basset, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2730 · Cited by 499
Mahmood, N., Mihalcioiu, C., & Rabbani, S. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00024 · Cited by 478
Plasmin and Matrix Metalloproteinases in Vascular Remodeling
Lijnen, H. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616230 · Cited by 453
Rønnov-Jessen, L., Petersen, O. W., Koteliansky, V. E., & Bissell, M. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117736 · Cited by 444
Thrombin receptor overexpression in malignant and physiological invasion processes
Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I., & Bar-Shavit, R. (1998) · Nature Medicine · doi:10.1038/nm0898-909 · Cited by 417
New insights into the molecular mechanisms of the fibrinolytic system
RIJKEN, D. C., & LIJNEN, H. R. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03220.x · Cited by 382
Adkison, A. M., Raptis, S. Z., Kelley, D. G., & Pham, C. T. N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213462 · Cited by 358
Bohuslav, J., Horejsí, V, Hansmann, C., Stöckl, J., Weidle, U. H., Majdic, O., Bartke, I., Knapp, W., & Stockinger, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1381 · Cited by 345
Powell, E. M., Campbell, D. B., Stanwood, G. D., Davis, C., Noebels, J. L., & Levitt, P. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00622.2003 · Cited by 337
Levitt, P., Eagleson, K. L., & Powell, E. M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.05.008 · Cited by 335
Powell, E. M., Mars, W. M., & Levitt, P. (2001) · Neuron · doi:10.1016/s0896-6273(01)00264-1 · Cited by 321
uPA and uPAR in fibrinolysis, immunity and pathology
Mondino, A., & Blasi, F. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.06.004 · Cited by 309
Self-citationJeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1115 · Cited by 307
Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00204976 · Cited by 288
Pathogenesis of postoperative adhesion formation
Hellebrekers, B. W. J., & Kooistra, T. (2011) · British Journal of Surgery · doi:10.1002/bjs.7657 · Cited by 282
Tian, J., Tang, Z. Y., Ye, S. L., Liu, Y. K., Lin, Z. Y., Chen, J., & Xue, Q. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690769 · Cited by 281
Allgayer, H., Babic, R., Gruetzner, K. U., Tarabichi, A., Schildberg, F. W., & Heiss, M. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2201 · Cited by 276
Functional overlap between two classes of matrix-degrading proteases in wound healing
Lund, L. R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4645 · Cited by 270
Upregulation of urokinase receptor expression on migrating endothelial cells
Pepper, M., Sappino, A., Stöcklin, R., Montesano, R., Orci, L., & Vassalli, J. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.3.673 · Cited by 270
LDL receptor‐related protein: a multiligand receptor for lipoprotein and proteinase catabolism
Strickland, D. K., Kounnas, M. Z., & Argraves, W. S. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615159 · Cited by 268
Levine, H. (2001) · Bulletin of Mathematical Biology · doi:10.1006/bulm.2001.0240 · Cited by 268
Elements of the Fibrinolytic System
LIJNEN, H. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03511.x · Cited by 253
Heiss, M. M., Allgayer, H., Gruetzner, K. U., Funke, I., Babic, R., Jauch, K.-W., & Schildberg, F. W. (1995) · Nature Medicine · doi:10.1038/nm1095-1035 · Cited by 252
Disruption of cerebral cortex MET signaling in autism spectrum disorder
Campbell, D. B., D'Oronzio, R., Garbett, K., Ebert, P. J., Mirnics, K., Levitt, P., & Persico, A. M. (2007) · Annals of Neurology · doi:10.1002/ana.21180 · Cited by 193
The development of hippocampal interneurons in rodents
Danglot, L., Triller, A., & Marty, S. (2006) · Hippocampus · doi:10.1002/hipo.20225 · Cited by 167
Leupold, J. H., Yang, H.-S., Colburn, N. H., Asangani, I., Post, S., & Allgayer, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210234 · Cited by 163
(1999) · PubMed · Cited by 158
Allgayer, H., Mahapatra, S., Mishra, B., Swain, B., Saha, S., Khanra, S., Kumari, K., Panda, V. K., Malhotra, D., Patil, N. S., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02338-2 · Cited by 127
The role of Pdcd4 in tumour suppression and protein translation
Wang, Q., & Yang, H. (2018) · Biology of the Cell · doi:10.1111/boc.201800014 · Cited by 113
Sato, T., Foged, N. T., & Delaissé, J.-M. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.1.59 · Cited by 98
Yamamoto, M., Ikeda, K., Ohshima, K., Tsugu, H., Kimura, H., & Tomonaga, M. (1998) · Brain Tumor Pathology · doi:10.1007/bf02482097 · Cited by 25
Metadata
- Authors
- Blasi, F.
- Venue
- BioEssays
- Publisher
- Wiley
- Published
- 1993-02
- Volume
- 15
- Issue
- 2
- Pages
- 105-111
- ISSN
- 0265-9247 (ISSN-L)
- 1521-1878
- OpenAlex
- W2088738897
- Cited by
- 395
- References
- 52
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.